Works by Hoving, Hilde D.
Results: 11
Synthesis and evaluation of 18F-enzalutamide, a new radioligand for PET Imaging of Androgen Receptors: A comparison with 16β18F-fluoro-5α-dihydrotestosterone.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.120.253641
- By:
- Publication type:
- Article
Synthesis and evaluation of <sup>18</sup>F-enzalutamide, a new radioligand for PET Imaging of Androgen Receptors: A comparison with 16β<sup>18</sup>F-fluoro-5α-dihydrotestosterone.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1
- By:
- Publication type:
- Article
Synthesis and evaluation of <sup>18</sup>F-enzalutamide, a new radioligand for PET Imaging of Androgen Receptors: A comparison with 16β-<sup>18</sup>F-fluoro-5α-dihydrotestosterone.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.120.253641
- By:
- Publication type:
- Article
Synthesis and evaluation of <sup>18</sup>F-enzalutamide, a new radioligand for PET Imaging of Androgen Receptors: A comparison with 16β<sup>18</sup>F-fluoro-5α-dihydrotestosterone.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 10, p. 1, doi. 10.2967/jnumed.120.253641
- By:
- Publication type:
- Article
Synthesis and evaluation of <sup>18</sup>F-enzalutamide, a new radioligand for PET Imaging of Androgen Receptors: A comparison with 16β-<sup>18</sup>F-fluoro-5α-dihydrotestosterone.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 8, p. 1, doi. 10.2967/jnumed.120.253641
- By:
- Publication type:
- Article
Synthesis and evaluation of <sup>18</sup>F-enzalutamide, a new radioligand for PET Imaging of Androgen Receptors: A comparison with 16β-<sup>18</sup>F-fluoro-5α-dihydrotestosterone.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 7, p. 1, doi. 10.2967/jnumed.120.253641
- By:
- Publication type:
- Article
Synthesis and evaluation of <sup>18</sup>F-enzalutamide, a new radioligand for PET Imaging of Androgen Receptors: A comparison with 16β-<sup>18</sup>F-fluoro-5α-dihydrotestosterone.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 6, p. 29, doi. 10.2967/jnumed.120.253641
- By:
- Publication type:
- Article
Synthesis and evaluation of <sup>18</sup>F-enzalutamide, a new radioligand for PET Imaging of Androgen Receptors: A comparison with 16β-<sup>18</sup>F-fluoro-5α-dihydrotestosterone.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 5, p. 1, doi. 10.2967/jnumed.120.253641
- By:
- Publication type:
- Article
Synthesis and evaluation of <sup>18</sup>F-enzalutamide, a new radioligand for PET Imaging of Androgen Receptors: A comparison with 16β-<sup>18</sup>F-fluoro-5α-dihydrotestosterone.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 3, p. 1, doi. 10.2967/jnumed.120.253641
- By:
- Publication type:
- Article
EpCAM Expression in Lymph Node and Bone Metastases of Prostate Carcinoma: A Pilot Study.
- Published in:
- International Journal of Molecular Sciences, 2016, v. 17, n. 10, p. 1650, doi. 10.3390/ijms17101650
- By:
- Publication type:
- Article
PSMA, EpCAM, VEGF and GRPR as Imaging Targets in Locally Recurrent Prostate Cancer after Radiotherapy.
- Published in:
- International Journal of Molecular Sciences, 2014, v. 15, n. 4, p. 6046, doi. 10.3390/ijms15046046
- By:
- Publication type:
- Article